In 2019, the Advisory Committee on Immunization Practices recommended patient-clinician shared decision-making for human papillomavirus vaccination in adults aged 27 to 45 years. Has the recommendation increased vaccine uptake in this age group?
Source: Suk R, Liao K, Bauer CX, et al. Human papillomavirus vaccine administration trends among commercially insured US adults aged 27-45 years before and after Advisory Committee on Immunization Practices recommendation change, 2007-2020. JAMA Health Forum. 2022;3:e224716. doi:10.1001/jamahealthforum.2022.4716.
In 2019, the Advisory Committee on Immunization Practices recommended patient-clinician shared decision-making for human papillomavirus vaccination in adults aged 27 to 45 years. Has the recommendation increased vaccine uptake in this age group?
Source: Suk R, Liao K, Bauer CX, et al. Human papillomavirus vaccine administration trends among commercially insured US adults aged 27-45 years before and after Advisory Committee on Immunization Practices recommendation change, 2007-2020. JAMA Health Forum. 2022;3:e224716. doi:10.1001/jamahealthforum.2022.4716.
In 2019, the Advisory Committee on Immunization Practices recommended patient-clinician shared decision-making for human papillomavirus vaccination in adults aged 27 to 45 years. Has the recommendation increased vaccine uptake in this age group?
Source: Suk R, Liao K, Bauer CX, et al. Human papillomavirus vaccine administration trends among commercially insured US adults aged 27-45 years before and after Advisory Committee on Immunization Practices recommendation change, 2007-2020. JAMA Health Forum. 2022;3:e224716. doi:10.1001/jamahealthforum.2022.4716.
